Notify me when Lance Friedman files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ASBP | Aspire Biopharma Holdings, Inc. | Common Stock | 4.5% | $1,037,706 | -$782,315 | 2,207,886 | -43% | Lance Friedman | 06 May 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|